focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.50
Bid: 38.00
Ask: 41.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.895%)
Open: 39.50
High: 39.50
Low: 39.50
Prev. Close: 39.50
EMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jan 2023 07:00

RNS Number : 8924N
Empresaria Group PLC
26 January 2023
 

26 January 2023

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading Update and Notice of Results

 

 

Solid net fee income growth with full year profits expected to be in line with market forecasts

Empresaria (AIM: EMR), the global specialist staffing group, today provides a trading update for the financial year ended 31 December 2022 ahead of announcing its full year results on 28 March 2023.

 

Trading update

 

· Net fee income up 10% to £65.4m (up 8% in constant currency)

· Adjusted profit before tax and diluted earnings per share expected to be in line with market expectations

· Adjusted net debt of £7.9m, significantly better than market expectations

· Very strong performance from APAC and Offshore Services with net fee income up 75%, outweighing reductions in UK & Europe and Americas

· Communicated roadmap to deliver our ambition to double adjusted operating profit in the medium term

 

The first half of the year saw greater growth (+15%) reflecting a strong recovery in client demand particularly for permanent placements. While solid growth continued into the third quarter, growth eased in the fourth quarter reflecting a strong prior year comparative and some reduction in demand from specific clients in key sectors such as IT.

 

The Group has continued to invest for the future and communicated its roadmap to double adjusted operating profit to £20m in the medium term at a capital markets day in October 2022. The actions outlined remain on track and delivery against this plan continues to be a key focus.

 

Financial position

 

Adjusted net debt has significantly reduced at 31 December 2022 to £7.9m, £6.1m lower than 31 December 2021 and £2.9m lower than 30 June 2022. This reflects the profits generated by the Group in the year, along with a reduction in working capital requirements driven by a move in the weighting of revenue from temporary and contract to permanent placements. Headroom, excluding invoice financing, has increased to £17.9m.

 

 

Performance by sector

 

Net fee income by sector for the year ended 31 December was as follows:

£m

2022

2021

% change

% change (constant currency)*

UK & Europe

28.4

29.0

-2%

-2%

APAC

15.8

14.1

+12%

+12%

Americas

8.7

9.9

-12%

-19%

Offshore Services

13.5

7.7

+75%

+67%

Intragroup

(1.0)

(1.2)

-17%

-17%

Total

65.4

59.5

+10%

+8%

* The constant currency movement is calculated by translating the 2021 results at the 2022 exchange rates.

 

The UK & Europe saw mixed performances in 2022 with net fee income falling by 2%. In the UK, net fee income was up by 3% with strong growth in Professional, driven by increased permanent placement demand, offset by a weaker performance in IT. In our blue-collar Commercial businesses in Germany, we saw good recovery in our logistics operation which returned to growth after a challenging 2021, however, our temporary business was adversely impacted by client supply chain issues earlier in the year and higher sickness levels resulting in net fee income falling year on year.

 

In APAC, year-on-year net fee income growth of 12% reflected strong performances across most of the region with record net fee income in Singapore, Indonesia, Philippines, Thailand and Japan driven by growth in our Professional and IT sectors. Aviation failed to improve significantly in 2022, with recovery in our core Asia market lagging behind that in the US and Europe, reflecting the continued closure of China throughout 2022 and significant restrictions on travel to Japan.

 

In the Americas, net fee income fell by 12% with the main driver being the expected reduction in Healthcare in the US following an extremely strong 2021 that was driven by COVID-19 vaccination and testing related demand. Our US IT business also had a challenging year, particularly in the second half where our permanent recruitment offering was impacted by significant technology lay-offs at key clients.

 

Offshore Services had a very strong 2022 with net fee income up 75% year-on-year. UK demand, driven by healthcare, remained very strong and continued to grow throughout the year. The US was more challenging primarily driven by reduced demand from the IT sector. 

 

Rhona Driggs, CEO of Empresaria, commented:

 

"We are pleased with our overall progress and performance in the year. As we move into 2023, we look ahead with some caution given the wider economic environment, however, we are continuing to see strong demand in many of our markets largely driven by ongoing skills and labour shortages.

 

The transformation of the Group in recent years, along with the proven benefits from our diversification by geography and sector, improves our resilience and provides us with a strong foundation for growth. Executing our 'Roadmap to £20m' remains our key focus and we are confident we are well placed to deliver on our medium-term ambition to double our adjusted operating profit."

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

- Ends -

 

Enquiries:

Empresaria Group plc Rhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Broker) Shaun Dobson / James Moat

020 7496 3000

Cenkos Securities plc (Joint Broker) Katy Birkin / Charlie Combe (Corporate Finance)Michael Johnson / Jasper Berry (Sales)

020 7397 3900

Alma PR (Financial PR) Sam Modlin

Hilary Buchanan

Pippa Crabtree

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group. We are driven by our purpose to positively impact the lives of people, while delivering exceptional talent to our clients globally. We offer temporary and contract recruitment, permanent recruitment and offshore services across six sectors: Professional, IT, Healthcare, Property, Construction & Engineering, Commercial and Offshore Services.

 

§ Empresaria is structured in four regions (UK & Europe, APAC, Americas and Offshore Services) and operates from locations across the world including the four largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIALRIEFIV
Date   Source Headline
8th Sep 20203:15 pmRNSDirector / PDMR Shareholding
18th Aug 20207:00 amRNSTransaction in Own Shares
12th Aug 20207:00 amRNSInterim Results
10th Aug 20207:00 amRNSInvestor Meet Company presentation
31st Jul 20207:00 amRNSRevision: Trading Update and Notice of Results
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
1st Jul 20203:36 pmRNSTransaction in Own Shares
30th Jun 202012:40 pmRNSTransaction in Own Shares
25th Jun 20208:54 amRNSTransaction in Own Shares
17th Jun 20205:18 pmRNSShare Buyback Programme
27th May 20201:04 pmRNSDirector/PDMR Shareholding
26th May 20201:23 pmRNSResult of AGM
26th May 20207:00 amRNSTrading update, acq. of non-controlling interest
8th Apr 20207:00 amRNSTrading and COVID-19 Update and Notice of AGM
30th Mar 20204:32 pmRNSAwards pursuant to the Company's LTIP
20th Mar 202012:08 pmRNSDirector/PDMR Shareholding
18th Mar 20201:10 pmRNSDirector Dealing
18th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSChange of Nominated Adviser and Broker
5th Feb 20202:53 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
3rd Dec 201910:36 amRNSDirector/PDMR Shareholding
14th Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20192:27 pmRNSHolding(s) in Company
30th Oct 20197:00 amRNSTrading and operational update
21st Aug 20197:00 amRNSInterim Results
24th Jul 20197:00 amRNSTrading Update
4th Jul 20197:00 amRNSAcquisition of non-controlling interest
27th Jun 20197:00 amRNSManagement Change
7th May 20192:31 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement and Notice of Results
1st Apr 20191:31 pmRNSAnnual Report and Accounts and Notice of AGM
25th Mar 20191:43 pmRNSAwards pursuant to the Company's LTIP
13th Mar 20197:00 amRNSFinal Results
1st Feb 201911:07 amRNSHolding(s) in Company
23rd Jan 20197:00 amRNSTrading Update and Notice of Results
13th Dec 20184:48 pmRNSVesting of Awards pursuant to the Company's LTIP
19th Nov 20187:00 amRNSChange of Auditor
22nd Oct 20187:00 amRNSAppointment of COO
6th Sep 201810:11 amRNSHolding(s) in Company
5th Sep 201811:17 amRNSHolding(s) in Company
29th Aug 201811:18 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSVesting of Awards pursuant to the Company's LTIP
22nd Aug 20187:00 amRNSInterim Results
27th Jul 20187:00 amRNSHolding(s) in Company
26th Jul 20184:38 pmRNSHolding(s) in Company
26th Jul 201810:39 amRNSHolding(s) in Company
25th Jul 20187:00 amRNSTrading Update and Notice of Results
17th Jul 20187:00 amRNSInvestment in Peru based Grupo Solimano
22nd Jun 201812:57 pmRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.